Advertisement

Topics

Contrast Induced Nephropathy Pipeline Review, H2 2017 [Report Updated: 08082017] Prices from USD $2000

23:20 EDT 20 Aug 2017 | BioPortfolio Reports

Contrast Induced Nephropathy Pipeline Review, H2 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Contrast Induced Nephropathy Pipeline Review, H2 2017, provides an overview of the Contrast Induced Nephropathy Genito Urinary System And Sex Hormones pipeline landscape.

Contrastinduced nephropathy CIN is defined as the impairment of renal function measured as either a 25%increase in serum creatinine SCr from baseline or a 0.5 mg/dL 44 mol/L increase in absolute SCr value after 4872 hrs contrast administration. Symptoms include feeling more tired, poor appetite, swelling in the feet and ankles, puffiness around the eyes, or dry and itchy skin. Risk factors include age, diabetes, decreased kidney function and congestive heart failure. Treatment includes electrolyte management.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Contrast Induced Nephropathy Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Contrast Induced Nephropathy Genito Urinary System And Sex Hormones, complete with analysis by stage of development, drug target, mechanism of action MoA, route of administration RoA and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Contrast Induced Nephropathy Genito Urinary System And Sex Hormones pipeline guide also reviews of key players involved in therapeutic development for Contrast Induced Nephropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II and Preclinical stages are 1 and 4 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Contrast Induced Nephropathy Genito Urinary System And Sex Hormones pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industryspecific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Contrast Induced Nephropathy Genito Urinary System And Sex Hormones.
The pipeline guide reviews pipeline therapeutics for Contrast Induced Nephropathy Genito Urinary System And Sex Hormones by companies and universities/research institutes based on information derived from company and industryspecific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from preregistration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, RD brief, MoA other developmental activities.
The pipeline guide reviews key companies involved in Contrast Induced Nephropathy Genito Urinary System And Sex Hormones therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Contrast Induced Nephropathy Genito Urinary System And Sex Hormones therapeutics based on mechanism of action MoA, drug target, route of administration RoA and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Contrast Induced Nephropathy Genito Urinary System And Sex Hormones

Reasons to buy

Procure strategically important competitor information, analysis, and insights to formulate effective RD strategies.
Recognize emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage.
Find and recognize significant and varied types of therapeutics under development for Contrast Induced Nephropathy Genito Urinary System And Sex Hormones.
Classify potential new clients or partners in the target demographic.
Develop tactical initiatives by understanding the focus areas of leading companies.
Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
Formulate corrective measures for pipeline projects by understanding Contrast Induced Nephropathy Genito Urinary System And Sex Hormones pipeline depth and focus of Indication therapeutics.
Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the knowhow what drove them from pipeline.

Original Article: Contrast Induced Nephropathy Pipeline Review, H2 2017 [Report Updated: 08082017] Prices from USD $2000

NEXT ARTICLE

More From BioPortfolio on "Contrast Induced Nephropathy Pipeline Review, H2 2017 [Report Updated: 08082017] Prices from USD $2000"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Urology
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...